首页 | 本学科首页   官方微博 | 高级检索  
     

印迹基因修饰使孤雌胚胎干细胞获得四倍体补偿能力
引用本文:李旭,彭柯力,张金鑫,高倩,张文豪,滑若彤,帅领. 印迹基因修饰使孤雌胚胎干细胞获得四倍体补偿能力[J]. 生物工程学报, 2019, 35(5): 910-918
作者姓名:李旭  彭柯力  张金鑫  高倩  张文豪  滑若彤  帅领
作者单位:南开大学 药学院 药物化学生物学国家重点实验室,天津 300350,南开大学 药学院 药物化学生物学国家重点实验室,天津 300350,南开大学 药学院 药物化学生物学国家重点实验室,天津 300350,南开大学 药学院 药物化学生物学国家重点实验室,天津 300350,南开大学 药学院 药物化学生物学国家重点实验室,天津 300350,南开大学 药学院 药物化学生物学国家重点实验室,天津 300350,南开大学 药学院 药物化学生物学国家重点实验室,天津 300350
基金项目:国家自然科学基金 (Nos. 31501186,31671538),天津市自然科学基金 (No. 31872841) 资助。
摘    要:孤雌胚胎干细胞(Parthenogenetic embryonic stem cells,pESCs)的遗传物质全部来源于母源基因组,因缺失父源基因而不具备四倍体补偿的能力。为了使pESCs也具备发育到个体的能力,呈现与受精卵来源ESCs类似的多能性,文中借助CRISPR/Cas9系统对孤雌来源的pESCs中的2个重要母源印迹基因的差异甲基化区域(Differentially methylated region,DMR)进行单等位基因敲除(H19-DMR,IG-DMR),获得双基因敲除的(DKO)pESCs。结果表明,pESCs虽然来源于母源基因组,但是其形态特征、多能干性标记分子的表达水平、体外神经分化能力与受精卵来源的ESCs基本一致。最后,通过基因修饰的DKOpESCs可以通过四倍体补偿获得发育到期的胎儿,表明经过印迹基因修饰的pESCs也具有发育到一个完整个体的多能性。从而为再生医学研究提供了一类具有主要组织相容性复合基因匹配且多能性良好的资源细胞。

关 键 词:孤雌胚胎干细胞,印迹基因,基因编辑,四倍体补偿
收稿时间:2018-12-06

Imprinting genes modified parthenogenetic embryonic stem cells produce full-term mouse via tetraploid complementation
Xu Li,Keli Peng,Jinxin Zhang,Qian Gao,Wenhao Zhang,Ruotong Hua and Ling Shuai. Imprinting genes modified parthenogenetic embryonic stem cells produce full-term mouse via tetraploid complementation[J]. Chinese journal of biotechnology, 2019, 35(5): 910-918
Authors:Xu Li  Keli Peng  Jinxin Zhang  Qian Gao  Wenhao Zhang  Ruotong Hua  Ling Shuai
Affiliation:State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300350, China,State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300350, China,State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300350, China,State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300350, China,State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300350, China,State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300350, China and State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300350, China
Abstract:Parthenogenetic embryonic stem cells (pESCs) derived from bi-maternal genomes do not have competency of tetraploid complementation, due to lacking of paternal imprinting genes. To make pESCs possess fully development potentials and similar pluripotency to zygote-derived ESCs, we knocked out one allelic gene of the two essential maternal imprinting genes (H19 and IG) in their differentially methylated regions (DMR) via CRISPR/Cas9 system and obtained double knock out (DKO) pESCs. Maternal pESCs had similar morphology, expression levels of pluripotent makers and in vitro neural differentiation potentials to zygotes-derived ESCs. Besides that, DKO pESCs could contribute to full-term fetuses through tetraploid complementation, proving that they held fully development potentials. Derivation of DKO pESCs provided a type of major histocompatibility complex (MHC) matched pluripotent stem cells, which would benefit research in regenerative medicine.
Keywords:parthenogenetic embryonic stem cells   imprinting genes   gene editing   tetraploid compensation
本文献已被 CNKI 等数据库收录!
点击此处可从《生物工程学报》浏览原始摘要信息
点击此处可从《生物工程学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号